Objective-Neuroimaging studies are promising components for a new diagnostic framework for bipolar disorder, but a major issue is the potential confound of psychotropic medication upon experimental measures. Withdrawing all individuals from medication and examining only unmedicated individuals may be clinically unfeasible, and examining only unmedicated individuals may render findings less generalizable.Method-The authors review structural and functional neuroimaging studies of medicated and unmedicated patients with bipolar disorder to discern the possible confounding effect of medication.Results-Findings from studies identified on MEDLINE that included medicated individuals with bipolar disorder indicated either no significant effect or ameliorative effects of psychotropic medications on abnormal structural and functional neuroimaging measures relevant to pathophysiologic mechanisms of the disorder. Different strategies for assessing medication effects are compared.Conclusions-Neuroimaging studies of bipolar disorder ideally should recruit both unmedicated and medicated individuals. Individuals who are unable to tolerate medication withdrawal likely have more severe illness and are especially informative for research examining biomarkers of illness and treatment response.The research agenda for DSM-V emphasizes the need for translating basic and clinical neuroscience research findings into a new classification system for psychiatric disorders based upon pathophysiologic and etiological processes (1,2). It also supports the recent call for such research to help create "rational treatment advances" in disorders such as bipolar depression (3) and the National Institute of Mental Health recommendation for the need to translate basic science discoveries into biomarkers, diagnostic tests, and new treatments for individuals with psychiatric disorders. Biological evidence of pathophysiologic processes can help meet critical challenges in psychiatric research by aiding the construction of diagnostic and treatment response groupings. This is particularly relevant to bipolar disorder, which is frequently either misdiagnosed or diagnosed late, often as unipolar depression in individuals without a clear previous history of manic episodes (4).Studies employing neuroimaging techniques, and functional neuroimaging techniques in particular, provide direct measures of neural system abnormalities that may be associated with different domains of pathology in bipolar disorder (2). These domains include abnormal emotion regulation and impaired cognitive control. A major issue for studies of psychiatric populations, however, is the potential confound of psychotropic medication upon Address correspondence and reprint requests to Dr. Phillips, Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Loeffler Building, 121 Meyran Ave., Pittsburgh, PA 15213; phillipsml@upmc.edu (e-mail). Dr. Fagiolini has been on the advisory boards and the speaker's bureaus of Bristol-Myer...